Back to Search
Start Over
P47.10 Neoadjuvant Osimertinib in EGFR-Mutant Stage IIIA/B NSCLC - A Phase 2 Open-Label Pilot Study.
- Source :
- Journal of Thoracic Oncology; 2021 Supplement, Vol. 16 Issue 10, pS1100-S1100, 1p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 16
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 153097390
- Full Text :
- https://doi.org/10.1016/j.jtho.2021.08.503